Covid-19 vaccination rates follow the money in states with the biggest wealth gaps, analysis shows
The affluent town of Woodbridge, Conn., has less than half the population of neighboring Ansonia,…
Author: STAT
STAT+: Drug maker will slash prices on cancer medicines to end price gouging probe in Europe
After months of deliberation, the European Commission has accepted an offer from Aspen Pharma to…
STAT+: Gilead’s Galapagos deal disintegrates, a black mark for CEO O’Day
The $5 billion deal that Gilead CEO Daniel O’Day presented as his signature move shortly…
STAT+: Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
Equip, a startup providing virtual therapy for eating disorders, raises $13 million
A vanguard of virtual behavioral health startups are attracting investor interest. The latest: Equip, which…
Opinion: America’s addiction crisis, compounded by Covid-19, requires immediate action to save lives
Despite hard-fought progress in recent years, new data from the Centers for Disease Control and…
Opinion: Back to ‘normal’ isn’t good enough
With the anticipation of increasing distribution of Covid-19 vaccines, Americans are looking forward to a…
Opinion: Do the math: Vaccines alone won’t get us out of this pandemic
As Covid-19 vaccines are being rolled out across the U.S., Americans seem to be heaving…
CDC director says ‘bruises are going to take a long time to heal’ at agency
The new director of the Centers for Disease Control and Prevention acknowledged that morale at…
Covid-19 cases are falling in the U.S. It could be a calm before a variant-driven storm
If the U.S. Covid-19 epidemic were a marathon, the country might have made it to…
The Biden administration is making nursing schools pay for a government mistake amid Covid-19
WASHINGTON — The federal government miscalculated funding for hospital-based nursing schools for nearly two decades,…
‘These numbers are incredibly important’: Doctors and lawmakers call on FDA to address racial disparities in pulse oximeters
A long-documented, under-the-radar disparity is garnering new attention as the Covid-19 pandemic stretches into another…
STAT+: House Democrats slip drug-pricing proposal into Covid-19 relief bill
WASHINGTON — House Democrats are expected to insert a controversial Medicaid drug pricing policy into…
STAT+: To delight of generic drug makers, federal appeals court tosses controversial ‘skinny labeling’ decision
In a surprising move, a federal appeals court panel may revisit a controversial decision that…
STAT+: Atul Gawande says Haven experience is helping shape his Covid-19 response work
The storied health tech startup Haven may have shuttered, but its famous former CEO, Atul…
STAT+: The Broad Institute’s new leader wants to ‘double down’ on biology
It has been an action-packed pandemic for the Broad Institute, the biomedical research center in…
STAT+: Pharmalittle: House to hold hearing on Covid-19 vaccine production; tug-of-war rages over who will be the next FDA commissioner
Rise and shine, everyone, another busy day is on the way. We can always tell,…
STAT+: STAT+ Conversations: A conversation on the FDA’s regulation of AI
Editors Note: A livestream of this conversation will be embedded below at 1:00p.m. ET. Every…
.jpg)
STAT+: In mid-stage study, KalVista pill halts swelling attacks caused by rare, genetic disease
KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced…
Opinion: The Biden administration needs to look beyond ICER for evaluating drug therapies
As breakthrough drugs stream out of biopharmaceutical laboratories, how much they should cost and who…
Opinion: Youths of color are our future. Investing in their mental health must be taken seriously
Gonzales is a small city in central California populated mostly by Latino immigrant families and…
Opinion: It’s not the ‘British variant.’ It’s B.1.1.7
When President Trump referred to the “Chinese virus,” the media were quick to point out…
STAT+: Woodcock vs. Sharfstein: A head-to-head comparison of Biden’s top choices for FDA commissioner
WASHINGTON — President Biden will soon have to nominate someone to helm the Food and…
A Q&A with WHO’s emergencies chief on Covid-19, why he’s hopeful, and when normalcy might return
This time last year, Mike Ryan, head of the World Health Organization’s health emergencies program,…
STAT+: Q&A: James ‘Jim’ Mullen on Editas, why he took the job as CEO, and his vision for the future
On Monday, Editas Medicines announced that veteran biopharma executive James “Jim” Mullen was expanding his…
Hospitals’ Covid-19 heroics have them poised for power in the new Washington
WASHINGTON — For frontline health care workers at hospitals, the Covid-19 pandemic has been a…
Opinion: A digital option is the right investment for at-home Covid-19 testing
The Biden administration’s recent investment of $230 million to expedite rapid production of the Ellume…
STAT+: A move to crack down on human rights, environmental abuses puts European pharma on notice
A new European plan to develop legislation to hold companies accountable for human rights abuses…
STAT+: Dueling endorsements emerge for FDA commissioner: Woodcock or Sharfstein?
As the White House struggles to address the pandemic and other pressing health matters, a…
STAT+: Pharmalittle: South Africa halts rollout of AstraZeneca Covid-19 vaccine; Pfizer to cut vaccine production time in half
Good morning, everyone, and welcome to another working week. We hope the weekend was somehow…
Opinion: Collaboration between the FDA and industry is essential to foster innovation in Alzheimer’s treatments
As the Food and Drug Administration moves closer to a decision about whether to approve…
Opinion: Telehealth’s critics have it right: The industry must evolve
For many people, January is a time for new beginnings. But for many telehealth patients,…
‘What other variants might be out there?’ An expert on viral evolution on what’s happening with coronavirus mutations
“Variants” is the latest term to leap from the infectious disease lexicon to the general…
STAT+: How a scientific journal’s ‘grotesque overreaction’ inflamed the contentious debate over Biogen’s Alzheimer’s drug
A science journal owned by the Alzheimer’s Association punished a trio of leading researchers after…
South Africa halts rollout of AstraZeneca’s Covid-19 vaccine after shot falters against variant
South Africa is halting its rollout of the AstraZeneca-University of Oxford Covid-19 vaccine, the country’s…
Opinion: The U.S. needs a National Vaccine Day
Vaccines don’t save lives. Vaccinations do. That is an essential lesson we have learned from…
.jpg)
STAT+: WTO is urged to ease trade rules so low-income countries can access drugs and vaccines
More than 100 advocacy groups from dozens of countries are urging the World Trade Organization…
STAT+: FDA blasts Keytruda data for new breast cancer indication as ‘questionable, immature, and unreliable’
Merck (MRK) may have readily turned its Keytruda cancer drug into a medical and financial…
STAT+: Wife of CytoDyn’s chairman sold $2.6 million in company stock ahead of Covid-19 drug study results
The wife of CytoDyn’s chairman sold $2.6 million in company stock before CytoDyn is expected…
STAT+: Pharmalittle: J&J seeks emergency use for its coronavirus vaccine; Merck says parasite drug does not work on Covid-19
And so, another working week will soon draw to a close. Not a moment too…
STAT+: 5 burning questions on the business of big genetics based on 23andMe’s filing to go public
It seemed a foregone conclusion: Despite the early popularity of companies offering health and ancestry…
Opinion: Public health is being undermined. These 10 actions can restore it
The year since the first Covid-19 case was identified in the United States has been…
Opinion: A buddy system can help doctors and nurses weather the Covid-19 maelstrom
Remember outings in elementary school or at camp? You were probably paired with another kid…
The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines
There is now real evidence that at least one coronavirus variant seems to elude some…
‘A waste of money’: The home Covid-19 test funded by the Biden administration is too costly and complex, critics say
For months, U.S. public health experts have called on the federal government to approve and…
Johnson & Johnson submits application for Covid-19 vaccine to FDA
Pharmaceutical giant Johnson & Johnson said Thursday it has applied to the Food and Drug…
Listen: 23andMe is going public, vaccine data abound, and Merck’s CEO is retiring
Is consumer DNA testing a good business? Are Covid-19 vaccines interchangeable? And how do you…
Opinion: NFL should discourage people from indoor Super Bowl parties
One of the cruelest aspects of Covid-19 is the danger it poses for joyous group…
STAT+: Fecal matter transplants could help certain cancer drugs work in more people, study shows
Checkpoint inhibitors like Keytruda and Opdivo can be incredibly powerful cancer-killing drugs — when they…
STAT+: The Pajama Interview: A conversation with Anne Wojcicki and Richard Branson
When consumer genetics firm 23andMe announced Thursday that it will go public through a deal…